middle.news
Mesoblast Prepares to Unveil FY2025 Results Amid Global Expansion
1:11am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Mesoblast Prepares to Unveil FY2025 Results Amid Global Expansion
1:11am on Saturday 30th of August, 2025 AEST
Key Points
Scheduled webcast for FY2025 financial results and operational update
FDA-approved Ryoncil therapy for pediatric steroid-refractory acute graft versus host disease
Ongoing development of additional cell therapies targeting inflammatory and cardiac conditions
Strong global intellectual property portfolio with patents extending to 2041
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MESOBLAST (ASX:MSB)
OPEN ARTICLE